VistaGen Therapeutics, Inc. Ownership
$0.24
4.10%
Nasdaq, Oct 09, 04:11 pm EDT.
Closed.
VistaGen Therapeutics, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Commodore Capital LP
|
2.789m | 6.28% | +2.789m | Jun 30 2026 |
| 2 |
Vanguard Capital Management, LLC
|
1.574m | 3.55% | — | Jun 30 2026 |
| 3 |
Two Sigma Investments, LP
|
847.992k | 1.91% | +361.878k | Jun 30 2026 |
| 4 |
Acadian Asset Management LLC
|
794.579k | 1.79% | +204.916k | Jun 30 2026 |
| 5 |
Renaissance Technologies LLC
|
730.500k | 1.65% | +439.200k | Jun 30 2026 |
|
1
Commodore Capital LP
|
6.28%
2.789m
|
|
2
Vanguard Capital Management, LLC
|
3.55%
1.574m
|
|
3
Two Sigma Investments, LP
|
1.91%
847.992k
|
|
4
Acadian Asset Management LLC
|
1.79%
794.579k
|
|
5
Renaissance Technologies LLC
|
1.65%
730.500k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 15.18% of VistaGen Therapeutics, Inc., with Commodore Capital LP the biggest at 6.28%, followed by Vanguard Capital Management, LLC (3.55%) and Two Sigma Investments, LP (1.91%). |
VistaGen Therapeutics, Inc. Short interest
Powered by
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in VistaGen Therapeutics, Inc. has held steady at around 8.5% of the float over the past 12 months. Short sellers' positioning has barely changed in this period. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
